1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, April 2017 (p4)

Biological Therapy Analysis & Statistics, April 2017 (p4)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

91-120 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Interferon Gamma-1B Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Interferon Gamma-1B Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Gamma-1B worldwide and by countries in North America, ...

  • Industries : Biological Therapy
  • Countries : World

Filgrastim Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Filgrastim Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Filgrastim worldwide and by countries in North America, Europe, Japan, BRIC, ...

  • Industries : Biological Therapy
  • Countries : World

Imiquimod Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Imiquimod Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Imiquimod worldwide and by countries in North America, Europe, Japan, BRIC, ...

  • Industries : Biological Therapy
  • Countries : World

The 2018-2023 World Outlook for Adult Stem Cell Research

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for adult stem cell research across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Next-generation Biologics

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for next-generation biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Cell Line Development

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for cell line development across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Stem Cell Technologies

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for stem cell technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Stem Cells

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Stem Cell Therapies

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for stem cell therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Mesenchymal Stem Cells (MSC)

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for mesenchymal stem cells (MSC) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Cell Cultures

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for cell cultures across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Brachytherapy Devices

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for brachytherapy devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Regenerative Medicine Ceramics

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for regenerative medicine ceramics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Stem Cell Treatments

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for stem cell treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Stem Cell Research

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for stem cell research across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Umbilical Cord Blood Stem Cells

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for umbilical cord blood stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for RNA Interference (RNAi) Technologies

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for RNA interference (RNAi) technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Tissue Engineering and Cell Therapies

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for tissue engineering and cell therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Gene Therapy

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for gene therapy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Stem Cell Services

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for stem cell services across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ...

  • Industries : Biological Therapy

The 2018-2023 World Outlook for Human Embryonic Stem Cell (hESC) Research

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for human embryonic stem cell (hESC) research across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Industries : Biological Therapy

CytoSorbents Corp (CTSO) - Product Pipeline Analysis, 2017 Update

  • $ 750
  • Company report
  • April 2017
  • by GlobalData

Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship ...

  • Industries : Health Facility, Biological Therapy, Therapy, Healthcare
  • Countries : United States, World

Human Stem Cells Institute (ISKJ) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2017
  • by GlobalData

Summary Human Stem Cells Institute (HSCI) is a biotechnology company that carries out the discovery, research and development, and marketing of proprietary products and services in the areas of regenerative ...

  • Industries : Biological Therapy

Protalix BioTherapeutics Inc (PLX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2017
  • by GlobalData

Summary Protalix BioTherapeutics Inc (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company’s pipeline products include PRX-102, a therapeutic ...

  • Industries : Biological Therapy

Aeglea BioTherapeutics Inc (AGLE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2017
  • by GlobalData

Summary Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment ...

International Stem Cell Corp (ISCO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2017
  • by GlobalData

Summary International Stem Cell Corp (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, which is a stem cell technology that improves the field ...

  • Industries : Biological Therapy

International Stem Cell Corp (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2017
  • by GlobalData

Summary International Stem Cell Corp (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, which is a stem cell technology that improves the field ...

  • Industries : Biological Therapy

Janus Biotherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2017
  • by GlobalData

Summary Janus Biotherapeutics Inc (Janus Biotherapeutics) develops therapies for the treatment of autoimmune diseases. The company develops oral compounds that aim to stop the abnormal toll-like recepto ...

Harvard Stem Cell Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2017
  • by GlobalData

Summary Harvard Stem Cell Institute (HSCI), a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments ...

Genenta Science srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2017
  • by GlobalData

Summary Genenta Science srl (Geneta Science) is a biotechnology company which develops new generation of gene therapies based on transcriptional and mirRNA-mediated control. The company develops gene transfe ...

  • Industries : Biological Therapy

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.